Galapagos NV ADR (GLPG)
Official siteBIOTECHNOLOGY
Last updated: May 07, 2026 at 5:00 PM ET
Galapagos NV ADR (GLPG) Financials: Revenue, Profit and Cash Flow
Galapagos NV ADR reported revenue of EUR 1.11B for the fiscal year ended Dec 31, 2025, up 303.5% from the year before. That year, net income was EUR 320.88M with a net margin of 28.9%, operating cash flow was EUR -189.23M and free cash flow was EUR -202.40M. The quarter ended Mar 31, 2026 had revenue of EUR 6.48M and net income of EUR 14.49M.
Revenue and Margins
The operating margin was 45.1% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from EUR 129.52M, a compound annual rate of 27.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 1.11B | +303.5% | 97.3% | 45.1% | 28.9% |
| Dec 2024 | 275.65M | +15.0% | 87.4% | -68.3% | 26.9% |
| Dec 2023 | 239.72M | -0.6% | 100.0% | -36.8% | 88.3% |
| Dec 2022 | 241.25M | -50.2% | 100.0% | -54.3% | -90.4% |
| Dec 2021 | 484.85M | +1.4% | 99.7% | -34.2% | -25.9% |
| Dec 2020 | 478.05M | -42.7% | -9.5% | -37.4% | -63.9% |
| Dec 2019 | 834.90M | +189.1% | 49.7% | 44.2% | 17.9% |
| Dec 2018 | 288.84M | +127.3% | -11.8% | -15.5% | -10.1% |
| Dec 2017 | 127.09M | -1.9% | -71.9% | -70.7% | -91.0% |
| Dec 2016 | 129.52M | N/A | -7.8% | -8.9% | 41.7% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 333.2% from the year before. In the quarter ended Mar 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11B | 275.65M | 239.72M | 241.25M | 484.85M | 478.05M | 834.90M | 288.84M | 127.09M | 129.52M |
| Cost of revenue | 29.74M | 34.86M | 38.91M | 31.43M | 1.63M | 523.67M | 420.09M | 322.88M | 218.50M | 139.57M |
| Gross profit | 1.08B | 240.79M | 239.72M | 241.25M | 483.22M | -45.61M | 414.81M | -34.04M | -91.42M | -10.06M |
| Research and development | 459.42M | 335.46M | 241.29M | 269.80M | 491.71M | 523.67M | 420.09M | 322.88M | 218.50M | 139.57M |
| Operating income | 501.39M | -188.34M | -88.26M | -131.06M | -165.60M | -178.63M | 368.75M | -44.81M | -89.80M | -11.49M |
| Net income | 320.88M | 74.08M | 211.70M | -217.99M | -125.42M | -305.44M | 149.84M | -29.26M | -115.70M | 54.01M |
| EBITDA | N/A | 43.33M | 51.04M | 3.87M | -100.93M | -170.67M | 374.24M | -28.87M | N/A | -8.16M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.48M | 900.82M | 71.16M | 65.29M | 74.98M | 75.50M | 59.85M | 77.87M | 62.43M | -209.12M | 120.03M | 149.95M |
| Gross profit | 1.68M | 900.37M | 60.31M | 60.58M | 61.25M | -37.43M | 59.83M | 61.32M | 59.88M | -209.12M | 114.33M | 145.69M |
| Operating income | -63.70M | 758.80M | -246.43M | -57.03M | -158.71M | -62.72M | -54.30M | -38.18M | -33.13M | -69.31M | -30.23M | -10.69M |
| Net income | 14.49M | 782.15M | -202.11M | -105.75M | -153.40M | 25.31M | -50.43M | 8.98M | 90.22M | 157.56M | 25.83M | 5.10M |
Balance Sheet
As of Dec 2025, the balance sheet showed EUR 87.83M in cash and equivalents and no debt.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.41B | 4.14B | 4.36B | 4.73B | 5.19B | 5.72B | 6.07B | 1.44B | 1.29B | 1.08B |
| Current assets | 3.08B | 3.34B | 3.86B | 4.24B | 4.86B | 5.37B | 5.87B | 1.33B | 1.20B | 1.01B |
| Cash and equivalents | 87.83M | 64.24M | 166.80M | 508.12M | 2.23B | 2.14B | 1.86B | 1.29B | 1.15B | 973.24M |
| Total liabilities | 170.58M | 1.24B | 1.56B | 2.21B | 2.55B | 3.05B | 3.19B | 225.25M | 274.29M | 324.64M |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.00K | 54.00K |
| Shareholder equity | 3.23B | 2.90B | 2.80B | 2.53B | 2.64B | 2.67B | 2.88B | 1.21B | 1.01B | 758.70M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.37B | 3.41B | 4.13B | 3.82B | 4.02B | 4.14B | 4.17B | 4.29B | 4.36B | 4.36B | 4.45B | 4.52B |
| Total liabilities | 119.06M | 170.65M | 1.25B | 1.17B | 1.27B | 1.24B | 1.31B | 1.38B | 1.47B | 1.56B | 1.83B | 1.94B |
| Cash and equivalents | 66.81M | 87.87M | 75.74M | 71.67M | 108.07M | 64.24M | 55.52M | 72.33M | 73.37M | 166.80M | 159.38M | 98.02M |
| Shareholder equity | 3.25B | 3.24B | 2.88B | 2.64B | 2.75B | 2.90B | 2.86B | 2.91B | 2.90B | 2.80B | 2.62B | 2.58B |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -189.23M | -320.03M | -405.97M | -500.54M | -503.83M | -427.34M | 3.60B | -142.47M | -147.03M | 239.40M |
| Capital expenditures | 13.16M | 82.11M | 19.27M | 36.95M | 57.88M | 91.31M | 25.05M | 13.72M | 7.44M | 4.79M |
| Free cash flow | -202.40M | -402.14M | -425.24M | -537.49M | -561.71M | -518.65M | 3.57B | -156.18M | -154.47M | 234.61M |
| Investing cash flow | 219.35M | 220.60M | 71.19M | -1.25B | 541.24M | 757.29M | -4.22B | -15.91M | -549.00K | -7.29M |
| Financing cash flow | -3.14M | -4.92M | -5.00M | -1.49M | -3.88M | 22.04M | 1.50B | 287.88M | 353.36M | 396.00M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -82.75M | -41.67M | -62.61M | -108.78M | -38.61M | -59.37M | -71.79M | -66.43M | -122.43M | -66.87M | -118.82M | -125.42M |
| Capital expenditures | 123.00K | 1.61M | 2.85M | 4.16M | 5.25M | 5.70M | 4.31M | 65.84M | 6.26M | 7.98M | 3.01M | 3.80M |
| Free cash flow | -82.87M | -43.28M | -65.46M | -112.94M | -43.86M | -65.07M | -76.10M | -132.27M | -128.70M | -74.84M | -121.83M | -129.22M |
Frequently Asked Questions About GLPG
What is Galapagos NV ADR's annual revenue?
Galapagos NV ADR reported revenue of EUR 1.11B for the fiscal year ended Dec 31, 2025.
How fast is Galapagos NV ADR's revenue growing?
Revenue was up 303.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 66.4%.
Is Galapagos NV ADR profitable?
Yes. Galapagos NV ADR reported net income of EUR 320.88M for the fiscal year ended Dec 31, 2025, with a net margin of 28.9%.
How much free cash flow does GLPG generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -189.23M minus capital expenditures of EUR 13.16M produced free cash flow of EUR -202.40M.
How much debt does Galapagos NV ADR have?
The balance sheet dated Dec 31, 2025 reported long-term debt of EUR 0, short-term debt of EUR 0 and cash and equivalents of EUR 87.83M.
GLPG pages: Overview, Financials